Antibody-enhanced Pneumococcal Adherence Requires IgA1 Protease

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2003 Mar 19

PMID 12642661

Citations 65

Authors

Jeffrey N Weiser

Deborah Bae

Claudine Fasching

Ronald W Scamurra

Adam J Ratner

Edward N Janoff

Affiliations

Soon will be listed here.

Abstract

IgA, the major class of Ig in secretions, classically functions by interfering with microbial attachment to host tissues. Many mucosal pathogens, including Streptococcus pneumoniae, express an IgA1 protease that may circumvent the protective effects of this Ig subclass. Because these proteases are specific for human IgA1, we generated human mAbs to the major surface antigen of the pneumococcus, its capsular polysaccharide, and tested their effect in a colonization model of bacterial adherence to respiratory epithelial cells in culture. Rather than inhibiting adherence, type-specific IgA1 markedly enhanced bacterial attachment to host cells, but only when cleaved by IgA1 protease. Neither antibodies of protease-insensitive subclasses (IgA2 and IgG) nor those directed against heterologous capsules had such activity. The adherence-promoting properties of cleaved antibodies correlated with the cationic characteristics of their variable segments, suggesting that bound Fab fragments may neutralize the inhibitory effect of negatively charged capsules on adhesive interaction with host cells. Coating of pneumococci with anticapsular polysaccharide antibody unmasked the bacterial phosphorylcholine ligand, allowing for increased adherence mediated by binding to the platelet activating factor receptor on epithelial cells. In addition, our findings provide evidence for a novel function of bacterial IgA1 proteases. These enzymes may enable pathogens to subvert the antigen specificity of the humoral immune response to facilitate adhesive interactions and persistence on the mucosal surface.

Citing Articles

Role of IgA1 protease-producing bacteria in SARS-CoV-2 infection and transmission: a hypothesis.

Russell M, Kilian M, Mestecky J mBio. 2024; 15(10):e0083324.

PMID: 39207101 PMC: 11492985. DOI: 10.1128/mbio.00833-24.

Mechanisms of antibody-dependent enhancement of infectious disease.

Wells T, Esposito T, Henderson I, Labzin L Nat Rev Immunol. 2024; 25(1):6-21.

PMID: 39122820 DOI: 10.1038/s41577-024-01067-9.

Antibody-dependent enhancement of toxicity of myotoxin II from Bothrops asper.

Sorensen C, Fernandez J, Adams A, Wildenauer H, Schoffelen S, Ledsgaard L Nat Commun. 2024; 15(1):173.

PMID: 38228619 PMC: 10791742. DOI: 10.1038/s41467-023-42624-5.

Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression.

Wang R, Song S, Qin J, Yoshimura K, Peng F, Chu Y Cancer Cell. 2023; 41(8):1407-1426.e9.

PMID: 37419119 PMC: 10528152. DOI: 10.1016/j.ccell.2023.06.005.

BlpC-mediated selfish program leads to rapid loss of Streptococcus pneumoniae clonal diversity during infection.

Aggarwal S, Lees J, Jacobs N, Bee G, Abruzzo A, Weiser J Cell Host Microbe. 2022; 31(1):124-134.e5.

PMID: 36395758 PMC: 9839470. DOI: 10.1016/j.chom.2022.10.015.

References

Kim J, Romero-Steiner S, Sorensen U, Blom J, Carvalho M, Barnard S . Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae. Infect Immun. 1999; 67(5):2327-33. PMC: 115974. DOI: 10.1128/IAI.67.5.2327-2333.1999. View

Carson P, Schut R, Simpson M, OBrien J, Janoff E . Antibody class and subclass responses to pneumococcal polysaccharides following immunization of human immunodeficiency virus-infected patients. J Infect Dis. 1995; 172(2):340-5. DOI: 10.1093/infdis/172.2.340. View

Kim J, Weiser J . Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis. 1998; 177(2):368-77. DOI: 10.1086/514205. View

Grundy F, Plaut A, Wright A . Haemophilus influenzae immunoglobulin A1 protease genes: cloning by plasmid integration-excision, comparative analyses, and localization of secretion determinants. J Bacteriol. 1987; 169(10):4442-50. PMC: 213806. DOI: 10.1128/jb.169.10.4442-4450.1987. View

Weiser J, Pan N, McGowan K, Musher D, Martin A, Richards J . Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J Exp Med. 1998; 187(4):631-40. PMC: 2212159. DOI: 10.1084/jem.187.4.631. View

Carroll W, Thielemans K, Dilley J, Levy R . Mouse x human heterohybridomas as fusion partners with human B cell tumors. J Immunol Methods. 1986; 89(1):61-72. DOI: 10.1016/0022-1759(86)90032-3. View

Weiser J, Bae D, Epino H, Gordon S, Kapoor M, Zenewicz L . Changes in availability of oxygen accentuate differences in capsular polysaccharide expression by phenotypic variants and clinical isolates of Streptococcus pneumoniae. Infect Immun. 2001; 69(9):5430-9. PMC: 98654. DOI: 10.1128/IAI.69.9.5430-5439.2001. View

Reinholdt J, Kilian M . Comparative analysis of immunoglobulin A1 protease activity among bacteria representing different genera, species, and strains. Infect Immun. 1997; 65(11):4452-9. PMC: 175640. DOI: 10.1128/iai.65.11.4452-4459.1997. View

Scamurra R, Miller D, Dahl L, Abrahamsen M, Kapur V, Wahl S . Impact of HIV-1 infection on VH3 gene repertoire of naive human B cells. J Immunol. 2000; 164(10):5482-91. DOI: 10.4049/jimmunol.164.10.5482. View

10.

Ring A, Weiser J, Tuomanen E . Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest. 1998; 102(2):347-60. PMC: 508893. DOI: 10.1172/JCI2406. View

11.

Wani J, Gilbert J, Plaut A, Weiser J . Identification, cloning, and sequencing of the immunoglobulin A1 protease gene of Streptococcus pneumoniae. Infect Immun. 1996; 64(10):3967-74. PMC: 174324. DOI: 10.1128/iai.64.10.3967-3974.1996. View

12.

Tyler B, Cole M . Effect of IgA1 protease on the ability of secretory IgA1 antibodies to inhibit the adherence of Streptococcus mutans. Microbiol Immunol. 1998; 42(7):503-8. DOI: 10.1111/j.1348-0421.1998.tb02316.x. View

13.

Opstad N, Daley C, Thurn J, Rubins J, Merrifield C, Hopewell P . Impact of Streptococcus pneumoniae bacteremia and human immunodeficiency virus type 1 on oral mucosal immunity. J Infect Dis. 1995; 172(2):566-70. DOI: 10.1093/infdis/172.2.566. View

14.

Lefkovits I, Waldmann H . Limiting dilution analysis of the cells of immune system I. The clonal basis of the immune response. Immunol Today. 2014; 5(9):265-8. DOI: 10.1016/0167-5699(84)90137-3. View

15.

Janoff E, Hardy W, Smith P, Wahl S . Humoral recall responses in HIV infection. Levels, specificity, and affinity of antigen-specific IgG. J Immunol. 1991; 147(7):2130-5. View

16.

Lacks S, HOTCHKISS R . A study of the genetic material determining an enzyme in Pneumococcus. Biochim Biophys Acta. 1960; 39:508-18. DOI: 10.1016/0006-3002(60)90205-5. View

17.

Engstrom P, Norhagen G, Bottaro A, Carbonara A, Lefranc G, Steinitz M . Subclass distribution of antigen-specific IgA antibodies in normal donors and individuals with homozygous C alpha 1 or C alpha 2 gene deletions. J Immunol. 1990; 145(1):109-16. View

18.

Mbelle N, Huebner R, Wasas A, Kimura A, Chang I, Klugman K . Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis. 1999; 180(4):1171-6. DOI: 10.1086/315009. View

19.

Fischer W, Behr T, Hartmann R, Peter-Katalinic J, EGGE H . Teichoic acid and lipoteichoic acid of Streptococcus pneumoniae possess identical chain structures. A reinvestigation of teichoid acid (C polysaccharide). Eur J Biochem. 1993; 215(3):851-7. DOI: 10.1111/j.1432-1033.1993.tb18102.x. View

20.

Reinholdt J, Kilian M . Interference of IgA protease with the effect of secretory IgA on adherence of oral streptococci to saliva-coated hydroxyapatite. J Dent Res. 1987; 66(2):492-7. DOI: 10.1177/00220345870660021801. View